Prestige Biopharma IDC Obtains International Certification for Environmental and Occupational Health and Safety Standards

Prestige Biopharma IDC, the new drug research and development subsidiary of Prestige Biopharma, announced on September 17 that it has obtained certification for ISO 14001, the international standard for environmental management systems, and ISO 45001, the international standard for occupational health and safety management systems.

ISO 14001 is an international standard designed to systematically manage and continually improve a company's environmental impact, while ISO 45001 is an international standard for identifying and managing occupational health and safety risks in the workplace.

Prestige Biopharma IDC established an international standard management system across quality, environment, and occupational health and safety by acquiring ISO 14001 and ISO 45001 certifications, following its achievement of the ISO 9001 international quality management system certification in January this year. The company plans to further enhance its quality, environmental, and occupational health and safety management frameworks going forward, aiming to minimize risks and build a stable research environment throughout the research and development process.

Sangseok Koh, CEO of Prestige Biopharma IDC, stated, "In order to develop innovative new drugs, it is important not only to have excellent research capabilities but also to maintain a safe and sustainable research environment. Now that we have expanded our certification system from ISO 9001 to include ISO 14001 and ISO 45001, we will continue to strengthen our international-level research and development (R&D) operations based on quality, environment, and occupational health and safety."

This content was produced with the assistance of AI translation services.